Invention Grant
- Patent Title: Methods for treatment of retinal disease by photoreceptor gene expression modulation
-
Application No.: US16447764Application Date: 2019-06-20
-
Publication No.: US10849904B2Publication Date: 2020-12-01
- Inventor: Thomas A. Reh , Paul Nakamura , Sheng Ding
- Applicant: University of Washington , The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
- Applicant Address: US WA Seattle US CA San Francisco
- Assignee: University of Washington,The J. David Gladstone Institutes, a Teatamentary Trust Established Under the Will of J. David. Gladstone
- Current Assignee: University of Washington,The J. David Gladstone Institutes, a Teatamentary Trust Established Under the Will of J. David. Gladstone
- Current Assignee Address: US WA Seattle US CA San Francisco
- Agency: Christensen O'Connor Johnson Kindness PLLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D495/04 ; A61K31/426 ; A61K9/00 ; A61P27/02
Abstract:
Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
Public/Granted literature
- US20190381047A1 METHODS FOR TREATMENT OF RETINAL DISEASE BY PHOTORECEPTOR GENE EXPRESSION MODULATION Public/Granted day:2019-12-19
Information query
IPC分类:
